Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
How long is the presymptomatic phase of multiple sclerosis?
Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.
Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease.
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Cytokine Therapies in Neurological Disease.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
Commentary on painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Stressful life events and the risk of initial central nervous system demyelination.
Automated multi-objective calibration of biological agent-based simulations.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Weighted-SAMGSR: combining significance analysis of microarray-gene set reduction algorithm with pathway topology-based weights to select relevant genes.
Diffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
The Impact of MS-Related Cognitive Fatigue on Future Brain Parenchymal Loss and Relapse: A 17-Month Follow-up Study.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke.
Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity.
Pages
« first
‹ previous
…
819
820
821
822
823
824
825
826
827
…
next ›
last »